2015 Form 10-K Financial Statement

#000119312515245476 Filed on July 06, 2015

View on sec.gov

Income Statement

Concept 2015 2014 Q2 2014 Q1
Revenue $17.63B $4.284B $4.377B
YoY Change -1.56% -2.88% -1.2%
Cost Of Revenue $11.52B $2.806B $2.871B
YoY Change -0.2% -1.82% -2.0%
Gross Profit $6.113B $1.482B $1.513B
YoY Change -4.03% -3.15% -0.66%
Gross Profit Margin 34.67% 34.6% 34.56%
Selling, General & Admin $3.283B $868.8M $834.2M
YoY Change -5.51% -7.08% -5.81%
% of Gross Profit 53.71% 58.61% 55.15%
Research & Development $229.4M
YoY Change -5.83%
% of Gross Profit 3.75%
Depreciation & Amortization $588.3M $143.3M $144.5M
YoY Change 0.5% -7.96% -1.16%
% of Gross Profit 9.62% 9.67% 9.55%
Operating Expenses $229.4M $868.8M $834.2M
YoY Change -93.83% -7.08% -5.81%
Operating Profit $5.884B $613.6M $678.5M
YoY Change 98.95% 3.02% 6.51%
Interest Expense -$523.0M -$71.80M -$77.00M
YoY Change -272.95% -25.98% 77.01%
% of Operating Profit -8.89% -11.7% -11.35%
Other Income/Expense, Net
YoY Change
Pretax Income $1.339B $602.5M $595.1M
YoY Change -38.64% 16.13% 5.23%
Income Tax $587.0M $203.7M $200.9M
% Of Pretax Income 43.85% 33.81% 33.76%
Net Earnings $1.259B $404.6M $410.6M
YoY Change -30.97% 10.46% 3.06%
Net Earnings / Revenue 7.14% 9.44% 9.38%
Basic Earnings Per Share $0.66 $0.66
Diluted Earnings Per Share $1.973M $0.65 $0.64
COMMON SHARES
Basic Shares Outstanding 603.3M shares 623.5M shares
Diluted Shares Outstanding 618.8M shares 640.2M shares

Balance Sheet

Concept 2015 2014 Q2 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $334.0M $867.0M $847.0M
YoY Change -61.48% 17.0% 12.78%
Cash & Equivalents $334.0M $867.3M $847.0M
Short-Term Investments
Other Short-Term Assets $275.0M $409.1M $502.0M
YoY Change -16.41% -6.51% 20.38%
Inventory $1.541B $1.559B $1.560B
Prepaid Expenses $187.2M
Receivables $1.387B $1.484B $1.648B
Other Receivables $149.0M $0.00 $0.00
Total Short-Term Assets $3.686B $4.394B $4.558B
YoY Change -16.11% 2.2% 4.4%
LONG-TERM ASSETS
Property, Plant & Equipment $3.783B $3.942B $3.797B
YoY Change -4.03% 1.65% -0.26%
Goodwill $8.651B
YoY Change 0.33%
Intangibles $5.014B
YoY Change -0.02%
Long-Term Investments $531.0M $507.5M $261.0M
YoY Change 4.53% 6.06% 234.62%
Other Assets $281.0M $1.146B $649.0M
YoY Change -55.96% 35.77% -20.56%
Total Long-Term Assets $18.15B $18.75B $18.37B
YoY Change -3.23% 2.14% -0.33%
TOTAL ASSETS
Total Short-Term Assets $3.686B $4.394B $4.558B
Total Long-Term Assets $18.15B $18.75B $18.37B
Total Assets $21.83B $23.15B $22.93B
YoY Change -5.68% 2.15% 0.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.684B $1.611B $1.360B
YoY Change 4.53% 13.22% 14.67%
Accrued Expenses $1.039B
YoY Change -7.56%
Deferred Revenue
YoY Change
Short-Term Debt $616.0M $1.112B $545.0M
YoY Change -44.6% 85.38% -20.2%
Long-Term Debt Due $1.000B $1.251B $1.204B
YoY Change -20.06% -13.31% 61.83%
Total Short-Term Liabilities $4.890B $5.424B $4.684B
YoY Change -9.85% 2.45% 9.36%
LONG-TERM LIABILITIES
Long-Term Debt $7.575B $6.424B $7.180B
YoY Change 17.92% 8.4% 8.26%
Other Long-Term Liabilities $1.745B $1.643B $1.822B
YoY Change 6.21% -15.86% -17.67%
Total Long-Term Liabilities $9.320B $1.643B $9.002B
YoY Change 15.53% -79.14% 1.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.890B $5.424B $4.684B
Total Long-Term Liabilities $9.320B $1.643B $9.002B
Total Liabilities $16.84B $15.16B $16.62B
YoY Change 1.35% 4.08% 5.32%
SHAREHOLDERS EQUITY
Retained Earnings $11.79B
YoY Change 10.13%
Common Stock $1.307B
YoY Change 5.25%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.219B
YoY Change 41.55%
Treasury Stock Shares 142.3M shares
Shareholders Equity $4.997B $6.535B $6.308B
YoY Change
Total Liabilities & Shareholders Equity $21.83B $23.15B $22.93B
YoY Change -5.68% 2.15% 0.58%

Cashflow Statement

Concept 2015 2014 Q2 2014 Q1
OPERATING ACTIVITIES
Net Income $1.259B $404.6M $410.6M
YoY Change -30.97% 10.46% 3.06%
Depreciation, Depletion And Amortization $588.3M $143.3M $144.5M
YoY Change 0.5% -7.96% -1.16%
Cash From Operating Activities $2.543B $816.8M $715.3M
YoY Change 0.07% 4.68% -13.67%
INVESTING ACTIVITIES
Capital Expenditures $712.4M -$247.1M -$147.6M
YoY Change 7.37% 22.51% -0.34%
Acquisitions $822.3M
YoY Change
Other Investing Activities $4.000M $115.6M $34.70M
YoY Change 344.44% -455.69% -216.05%
Cash From Investing Activities -$1.602B -$131.5M -$112.9M
YoY Change 185.19% -43.85% -36.57%
FINANCING ACTIVITIES
Cash Dividend Paid $1.018B
YoY Change 3.5%
Common Stock Issuance & Retirement, Net $1.162B
YoY Change -33.43%
Debt Paid & Issued, Net $1.146B
YoY Change -20.69%
Cash From Financing Activities -$1.385B -653.9M -516.0M
YoY Change -24.08% 20.89% -18.48%
NET CHANGE
Cash From Operating Activities $2.543B 816.8M 715.3M
Cash From Investing Activities -$1.602B -131.5M -112.9M
Cash From Financing Activities -$1.385B -653.9M -516.0M
Net Change In Cash -$444.2M 31.40M 86.40M
YoY Change -386.4% 503.85% 390.91%
FREE CASH FLOW
Cash From Operating Activities $2.543B $816.8M $715.3M
Capital Expenditures $712.4M -$247.1M -$147.6M
Free Cash Flow $1.830B $1.064B $862.9M
YoY Change -2.51% 8.34% -11.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2253200000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2015 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
20700000 USD
CY2015 gis Treasury Stock Aggregate Value Acquired
TreasuryStockAggregateValueAcquired
1161900000 USD
CY2013 gis Redeemable Interest Fair Value Increase Decrease
RedeemableInterestFairValueIncreaseDecrease
-93100000 USD
CY2013 gis Treasury Stock Aggregate Value Acquired
TreasuryStockAggregateValueAcquired
1044900000 USD
CY2014 gis Treasury Stock Aggregate Value Acquired
TreasuryStockAggregateValueAcquired
1745300000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
108500000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
100400000 USD
CY2014 gis Minority Interest Decrease From Distributions To Noncontrolling And Redeemable Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingAndRedeemableInterestHolders
28200000 USD
CY2013 gis Minority Interest Decrease From Distributions To Noncontrolling And Redeemable Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingAndRedeemableInterestHolders
23000000 USD
CY2015 gis Minority Interest Decrease From Distributions To Noncontrolling And Redeemable Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingAndRedeemableInterestHolders
25900000 USD
CY2014 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
17600000 USD
CY2015 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
9900000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
106400000 USD
CY2015 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
74600000 USD
CY2015 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
72600000 USD
CY2015 us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
49500000 USD
CY2015 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
91300000 USD
CY2015 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
531100000 USD
CY2015 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-214700000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2542800000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2541000000 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
585400000 USD
CY2014 us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
49700000 USD
CY2014 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
32200000 USD
CY2014 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-76200000 USD
CY2014 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
124100000 USD
CY2013 us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
223200000 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
588000000 USD
CY2013 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-471100000 USD
CY2013 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
-60200000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2926000000 USD
CY2013 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
131200000 USD
CY2013 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
898000000 USD
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
24200000 USD
CY2013 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2015 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4000000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1602200000 USD
CY2015 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-509800000 USD
CY2015 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1145800000 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
163700000 USD
CY2015 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
74600000 USD
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1161900000 USD
CY2015 us-gaap Payments Of Dividends
PaymentsOfDividends
1017700000 USD
CY2015 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-16100000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1384800000 USD
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-88900000 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-533100000 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6800000 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
24200000 USD
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
50500000 USD
CY2015 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
145800000 USD
CY2015 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
136800000 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
44600000 USD
CY2012Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
471200000 USD
CY2015 gis Distributions To Noncontrolling And Redeemable Interest Holders
DistributionsToNoncontrollingAndRedeemableInterestHolders
25000000 USD
CY2015 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
27900000 USD
CY2015 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
CY2014 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
17600000 USD
CY2013 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
CY2013 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
115700000 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
100400000 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
81800000 USD
CY2013 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
103000000 USD
CY2014 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
90500000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
108500000 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
172500000 USD
CY2014 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
69300000 USD
CY2013 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
16200000 USD
CY2015 us-gaap Basis Of Accounting
BasisOfAccounting
<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">NOTE</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">1</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">BASIS OF PRESENTATION AND RECLASSIFICATIONS</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Basis of Presentation</font></p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Our Consolidated Financial Statements include the accounts of General Mills, Inc. and all subsidiaries in which we </font><font style="font-family:Times New Roman;font-size:10pt;">have a controlling financial interest. Intercompany transactions and accounts</font><font style="font-family:Times New Roman;font-size:10pt;">, including any </font><font style="font-family:Times New Roman;font-size:10pt;">noncontrolling</font><font style="font-family:Times New Roman;font-size:10pt;"> and redeemable interests' share of those transactions,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">are eliminated in consolidation.</font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Our fiscal year ends on the</font><font style="font-family:Times New Roman;font-size:10pt;"> last Sunday in May</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> Fiscal </font><font style="font-family:Times New Roman;font-size:10pt;">year 2015 consisted of 53 weeks, while fiscal years</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">2014 and 2013 </font><font style="font-family:Times New Roman;font-size:10pt;">consisted of 52 weeks.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Change in Reporting Period</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">As part of a long-term plan to conform the fiscal year ends of all our operations, </font><font style="font-family:Times New Roman;font-size:10pt;">in fiscal 2013 we</font><font style="font-family:Times New Roman;font-size:10pt;"> changed the reporting period of </font><font style="font-family:Times New Roman;font-size:10pt;">Europe and Australia</font><font style="font-family:Times New Roman;font-size:10pt;"> within our International segment from an April fiscal year end to a May fiscal year end to match our fiscal calendar. Accordingly, in the year of change, our results include</font><font style="font-family:Times New Roman;font-size:10pt;">d</font><font style="font-family:Times New Roman;font-size:10pt;"> 13 months of results from the affected operations compared to 12 months in </font><font style="font-family:Times New Roman;font-size:10pt;">following</font><font style="font-family:Times New Roman;font-size:10pt;"> fiscal years. The impact of these changes was not material to our</font><font style="font-family:Times New Roman;font-size:10pt;"> consolidated</font><font style="font-family:Times New Roman;font-size:10pt;"> results of operations</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Our</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">Yoplait</font><font style="font-family:Times New Roman;font-size:10pt;"> S</font><font style="font-family:Times New Roman;font-size:10pt;">AS</font><font style="font-family:Times New Roman;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;">Yoplait Marques SNC</font><font style="font-family:Times New Roman;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;">Yoki</font><font style="font-family:Times New Roman;font-size:10pt;"> Alimentos S.A. (</font><font style="font-family:Times New Roman;font-size:10pt;">Yoki</font><font style="font-family:Times New Roman;font-size:10pt;">)</font><font style="font-family:Times New Roman;font-size:10pt;">, and India businesses </font><font style="font-family:Times New Roman;font-size:10pt;">remain on an April fiscal year end</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'>&#160;</p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Certain reclassifications to our previously reported financial information have been made to conform to the current period presentation.</font></p>
CY2015 gis Annual Reporting Period Months
AnnualReportingPeriodMonths
P12M
CY2014 gis Annual Reporting Period Weeks
AnnualReportingPeriodWeeks
52
CY2013 gis Annual Reporting Period Weeks
AnnualReportingPeriodWeeks
52
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Use of Estimates</font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Preparing our Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. These estimates include our accounting for promotional expenditures, valuation of long-lived assets, intangible assets,</font><font style="font-family:Times New Roman;font-size:10pt;"> redeemable interest,</font><font style="font-family:Times New Roman;font-size:10pt;"> stock-based compensation, income taxes, and defined benefit pension, </font><font style="font-family:Times New Roman;font-size:10pt;">other </font><font style="font-family:Times New Roman;font-size:10pt;">p</font><font style="font-family:Times New Roman;font-size:10pt;">ost</font><font style="font-family:Times New Roman;font-size:10pt;">retirement </font><font style="font-family:Times New Roman;font-size:10pt;">benefit </font><font style="font-family:Times New Roman;font-size:10pt;">and post</font><font style="font-family:Times New Roman;font-size:10pt;">employment benefit plans</font><font style="font-family:Times New Roman;font-size:10pt;">. Actual results could differ from our estimates.</font></p>
CY2015 us-gaap Severance Costs1
SeveranceCosts1
178200000 USD
CY2015 us-gaap Asset Impairment Charges
AssetImpairmentCharges
55300000 USD
CY2015 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
-37800000 USD
CY2015 us-gaap Other Restructuring Costs
OtherRestructuringCosts
19100000 USD
CY2015 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
53100000 USD
CY2015 us-gaap Restructuring Charges
RestructuringCharges
343500000 USD
CY2015 gis Other Project Related Costs
OtherProjectRelatedCosts
13200000 USD
CY2014 gis Other Project Related Costs
OtherProjectRelatedCosts
0 USD
CY2013 gis Other Project Related Costs
OtherProjectRelatedCosts
0 USD
CY2013 us-gaap Restructuring Charges
RestructuringCharges
19800000 USD
CY2014 us-gaap Restructuring Charges
RestructuringCharges
3600000 USD
CY2012Q2 us-gaap Restructuring Reserve
RestructuringReserve
85900000 USD
CY2013Q2 us-gaap Restructuring Reserve
RestructuringReserve
19500000 USD
CY2014Q2 us-gaap Restructuring Reserve
RestructuringReserve
3500000 USD
CY2015Q2 us-gaap Restructuring Reserve
RestructuringReserve
120800000 USD
CY2013 gis Increase In Restructuring Reserve
IncreaseInRestructuringReserve
10600000 USD
CY2013 gis Decrease In Restructuring Reserve
DecreaseInRestructuringReserve
77000000 USD
CY2014 gis Increase In Restructuring Reserve
IncreaseInRestructuringReserve
6400000 USD
CY2014 gis Decrease In Restructuring Reserve
DecreaseInRestructuringReserve
22400000 USD
CY2015 gis Decrease In Restructuring Reserve
DecreaseInRestructuringReserve
67800000 USD
CY2015 gis Increase In Restructuring Reserve
IncreaseInRestructuringReserve
185100000 USD
CY2015 us-gaap Payments For Restructuring
PaymentsForRestructuring
63600000 USD
CY2013 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
1057300000 USD
CY2014 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
1030300000 USD
CY2015 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
925400000 USD
CY2015 gis Equity Method Investments Summarized Financial Information Income Loss From Continuing Operations Before Income Taxes
EquityMethodInvestmentsSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeIncomeTaxes
220900000 USD
CY2014 gis Equity Method Investments Summarized Financial Information Income Loss From Continuing Operations Before Income Taxes
EquityMethodInvestmentsSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeIncomeTaxes
219100000 USD
CY2013 gis Equity Method Investments Summarized Financial Information Income Loss From Continuing Operations Before Income Taxes
EquityMethodInvestmentsSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeIncomeTaxes
260300000 USD
CY2015 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
170700000 USD
CY2014 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
168800000 USD
CY2013 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
201600000 USD
CY2015 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
2264700000 USD
CY2014 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
2494800000 USD
CY2013 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
2552700000 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
800100000 USD
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
1031100000 USD
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
1129800000 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
962100000 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
1484800000 USD
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
1779000000 USD
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
110300000 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
118200000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
414900000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
510200000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
129100000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
120500000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
544000000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
630700000 USD
CY2015Q2 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
4262100000 USD
CY2015 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
6500000 USD
CY2015 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
0 USD
CY2014 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
0 USD
CY2014Q2 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
4504100000 USD
CY2015Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
13551900000 USD
CY2014Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
13664800000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
28000000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
28000000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
28000000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
28000000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
28000000 USD
CY2014Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 USD
CY2014Q4 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2015 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
589800000 USD
CY2014 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
-12200000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
8622200000 USD
CY2012Q2 us-gaap Goodwill
Goodwill
8182500000 USD
CY2013 us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
32700000 USD
CY2015 us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-365400000 USD
CY2014 us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
40500000 USD
CY2013 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
407000000 USD
CY2013 us-gaap Indefinite Lived Intangible Assets Translation And Purchase Accounting Adjustments
IndefiniteLivedIntangibleAssetsTranslationAndPurchaseAccountingAdjustments
-500000 USD
CY2014 us-gaap Indefinite Lived Intangible Assets Translation And Purchase Accounting Adjustments
IndefiniteLivedIntangibleAssetsTranslationAndPurchaseAccountingAdjustments
-800000 USD
CY2015 us-gaap Indefinite Lived Intangible Assets Translation And Purchase Accounting Adjustments
IndefiniteLivedIntangibleAssetsTranslationAndPurchaseAccountingAdjustments
-345700000 USD
CY2012Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4704900000 USD
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5015100000 USD
CY2013 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
310700000 USD
CY2015 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
268400000 USD
CY2015 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
260000000 USD
CY2015Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
4400000 USD
CY2014Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
320400000 USD
CY2015Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
10900000 USD
CY2014 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
5600000 USD
CY2014Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
326000000 USD
CY2014 gis Net Loss Gain On Commodity Positions Reclassified From Unallocated Corporate Items To Segment Operating Profit
NetLossGainOnCommodityPositionsReclassifiedFromUnallocatedCorporateItemsToSegmentOperatingProfit
-51200000 USD
CY2014 us-gaap Gain Loss On Price Risk Derivative Instruments Not Designated As Hedging Instruments
GainLossOnPriceRiskDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-4900000 USD
CY2014 gis Net Mark To Market Valuation Of Certain Commodity Positions Recognized In Unallocated Corporate Items
NetMarkToMarketValuationOfCertainCommodityPositionsRecognizedInUnallocatedCorporateItems
48500000 USD
CY2015Q2 gis Unrealized Gain Loss On Interest Rate Cash Flow Hedges Pre Tax Accumulated Other Comprehensive Income1
UnrealizedGainLossOnInterestRateCashFlowHedgesPreTaxAccumulatedOtherComprehensiveIncome1
-60100000 USD
CY2015 us-gaap Gain Loss On Price Risk Derivative Instruments Not Designated As Hedging Instruments
GainLossOnPriceRiskDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-163700000 USD
CY2015 gis Net Loss Gain On Commodity Positions Reclassified From Unallocated Corporate Items To Segment Operating Profit
NetLossGainOnCommodityPositionsReclassifiedFromUnallocatedCorporateItemsToSegmentOperatingProfit
-84400000 USD
CY2015 us-gaap Increase Decrease In Fair Value Of Hedged Item In Price Risk Fair Value Hedge1
IncreaseDecreaseInFairValueOfHedgedItemInPriceRiskFairValueHedge1
-10400000 USD
CY2015 gis Net Mark To Market Valuation Of Certain Commodity Positions Recognized In Unallocated Corporate Items
NetMarkToMarketValuationOfCertainCommodityPositionsRecognizedInUnallocatedCorporateItems
-89700000 USD
CY2013 us-gaap Gain Loss On Price Risk Derivative Instruments Not Designated As Hedging Instruments
GainLossOnPriceRiskDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-7600000 USD
CY2013 gis Net Loss Gain On Commodity Positions Reclassified From Unallocated Corporate Items To Segment Operating Profit
NetLossGainOnCommodityPositionsReclassifiedFromUnallocatedCorporateItemsToSegmentOperatingProfit
-13700000 USD
CY2013 gis Net Mark To Market Valuation Of Certain Commodity Positions Recognized In Unallocated Corporate Items
NetMarkToMarketValuationOfCertainCommodityPositionsRecognizedInUnallocatedCorporateItems
4400000 USD
CY2013 us-gaap Increase Decrease In Fair Value Of Hedged Item In Price Risk Fair Value Hedge1
IncreaseDecreaseInFairValueOfHedgedItemInPriceRiskFairValueHedge1
-1700000 USD
CY2014 us-gaap Increase Decrease In Fair Value Of Hedged Item In Price Risk Fair Value Hedge1
IncreaseDecreaseInFairValueOfHedgedItemInPriceRiskFairValueHedge1
2200000 USD
CY2015Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
40000000 USD
CY2015Q2 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2015Q2 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
40000000 USD
CY2015Q2 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
13800000 USD
CY2015Q2 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2015Q2 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
26200000 USD
CY2015Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
124700000 USD
CY2015Q2 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2015Q2 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
124700000 USD
CY2015Q2 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
13800000 USD
CY2015Q2 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
40100000 USD
CY2015Q2 us-gaap Additional Collateral Aggregate Fair Value
AdditionalCollateralAggregateFairValue
56500000 USD
CY2015Q2 us-gaap Line Of Credit
LineOfCredit
200000000 USD
CY2014Q2 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2014Q2 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
18900000 USD
CY2014Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
23100000 USD
CY2014Q2 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2014Q2 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
23100000 USD
CY2014Q2 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
11400000 USD
CY2014Q2 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 USD
CY2014Q2 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
11700000 USD
CY2015Q2 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
70800000 USD
CY2014Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
30300000 USD
CY2014Q2 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2014Q2 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
30300000 USD
CY2014Q2 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
11400000 USD
CY2015Q2 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
203000000 USD
CY2015Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
246300000 USD
CY2015Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
132500000 USD
CY2015Q2 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
0 USD
CY2014Q2 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
326000000 USD
CY2014Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
363800000 USD
CY2014Q2 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
0 USD
CY2014Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
28000000 USD
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
-28800000 USD
CY2015Q2 us-gaap Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
8996600000 USD
CY2015 us-gaap Concentration Risk Credit Risk Financial Instrument Maximum Exposure
ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
16700000 USD
CY2015Q2 gis Accounts Payable To Suppliers That Utilize Third Party Service
AccountsPayableToSuppliersThatUtilizeThirdPartyService
448600000 USD
CY2015 us-gaap Maximum Length Of Time Foreign Currency Cash Flow Hedge
MaximumLengthOfTimeForeignCurrencyCashFlowHedge
P18M
CY2015Q2 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
81500000 USD
CY2015Q2 us-gaap Other Secured Financings
OtherSecuredFinancings
4100000 USD
CY2015Q2 gis Hedge Gain Loss To Be Reclassified During Next Twelve Months Net
HedgeGainLossToBeReclassifiedDuringNextTwelveMonthsNet
2300000 USD
CY2015Q2 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
25000000 USD
CY2015 us-gaap Gain Loss On Interest Rate Fair Value Hedge Ineffectiveness
GainLossOnInterestRateFairValueHedgeIneffectiveness
1600000 USD
CY2015Q2 gis Deferred Net Foreign Currency Transaction Gains Losses Aftertax Accumulated Other Comprehensive Income
DeferredNetForeignCurrencyTransactionGainsLossesAftertaxAccumulatedOtherComprehensiveIncome
10700000 USD
CY2014Q2 us-gaap Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
0.013 pure
CY2015Q2 us-gaap Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
0.030 pure
CY2015Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
3400000000 USD
CY2014Q2 gis Long Term Debt And Capital Lease Obligations Aggregate
LongTermDebtAndCapitalLeaseObligationsAggregate
7674100000 USD
CY2015Q2 gis Long Term Debt And Capital Lease Obligations Aggregate
LongTermDebtAndCapitalLeaseObligationsAggregate
8608100000 USD
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1000400000 USD
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
604500000 USD
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1150200000 USD
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
500100000 USD
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1103400000 USD
CY2015Q2 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
-10600000 USD
CY2015Q2 us-gaap Other Minority Interests
OtherMinorityInterests
8200000 USD
CY2015 gis Number Of Other Minority Interests
NumberOfOtherMinorityInterests
6 subsidiaries
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-536600000 USD
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3700000 USD
CY2015Q2 gis Accumulated Other Comprehensive Income Loss Net Actuarial Gain Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetActuarialGainLossNetOfTax
-1756100000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
191300000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2900000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
-38800000 USD
CY2014Q2 gis Accumulated Other Comprehensive Income Loss Net Actuarial Gain Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetActuarialGainLossNetOfTax
-1469200000 USD
CY2015Q2 gis Accumulated Other Comprehensive Income Loss Prior Service Costs Net Of Tax
AccumulatedOtherComprehensiveIncomeLossPriorServiceCostsNetOfTax
-7100000 USD
CY2014Q2 gis Accumulated Other Comprehensive Income Loss Prior Service Costs Net Of Tax
AccumulatedOtherComprehensiveIncomeLossPriorServiceCostsNetOfTax
26500000 USD
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
100000000 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.026 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.026 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.03
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.65
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.22
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.173 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.174 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.175 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.035 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.031 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.031 pure
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P8Y6M
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P9Y
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P9Y
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed
The valuation of stock options is a significant accounting estimate that requires us to use judgments and assumptions that are likely to have a material impact on our financial statements. We estimate the fair value of each option on the grant date using a Black-Scholes option-pricing model, which requires us to make predictive assumptions regarding future stock price volatility, employee exercise behavior, dividend yield, and the forfeiture rate. We estimate our future stock price volatility using the historical volatility over the expected term of the option, excluding time periods of volatility we believe a marketplace participant would exclude in estimating our stock price volatility. We also have considered, but did not use, implied volatility in our estimate, because trading activity in options on our stock, especially those with tenors of greater than 6 months, is insufficient to provide a reliable measure of expected volatility. Our expected term represents the period of time that options granted are expected to be outstanding based on historical data to estimate option exercises and employee terminations within the valuation model. Separate groups of employees have similar historical exercise behavior and therefore were aggregated into a single pool for valuation purposes. The weighted-average expected term for all employee groups is presented in the table above. The risk-free interest rate for periods during the expected term of the options is based on the U.S. Treasury zero-coupon yield curve in effect at the time of grant.
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.96
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
60942700 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
25.27
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
39564900 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.22
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
34.06
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
47672100 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
3407700 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
27.69
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
29290300 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
32.10
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
38.74
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2789800 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
44169000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
28.37
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
29452800 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
34.35
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
43.73
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
39077200 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2253100 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
30.44
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
26991500 shares
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
53.70
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
26.68
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
38.15
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
23.49
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
48.33
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
24.78
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
16534600 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
143700 shares
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6181300 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
111600 shares
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7297200 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
47700 shares
CY2015 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
163700000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
201900000 USD
CY2014 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
108100000 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
166600000 USD
CY2013 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
300800000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
297200000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1708200 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
53.45
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
48.49
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2144100 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
38.41
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2404900 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
27100000 shares
CY2015Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
101900000 USD
CY2015 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y5M
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
603300000 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
618800000 shares
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
645700000 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
628600000 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
648600000 shares
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
665600000 shares
CY2015 gis Amount Of Dilutive Securities Restricted Stock Units
AmountOfDilutiveSecuritiesRestrictedStockUnits
4200000 shares
CY2014 gis Amount Of Dilutive Securities Stock Options
AmountOfDilutiveSecuritiesStockOptions
12300000 shares
CY2014 gis Amount Of Dilutive Securities Restricted Stock Units
AmountOfDilutiveSecuritiesRestrictedStockUnits
4800000 shares
CY2015 gis Amount Of Dilutive Securities Stock Options
AmountOfDilutiveSecuritiesStockOptions
11300000 shares
CY2013 gis Amount Of Dilutive Securities Stock Options
AmountOfDilutiveSecuritiesStockOptions
12000000 shares
CY2013 gis Amount Of Dilutive Securities Restricted Stock Units
AmountOfDilutiveSecuritiesRestrictedStockUnits
5000000 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2100000 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1700000 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000 shares
CY2015 us-gaap Defined Benefit Plan Ultimate Health Care Cost Trend Rate
DefinedBenefitPlanUltimateHealthCareCostTrendRate
0.05 pure
CY2014 us-gaap Defined Benefit Plan Ultimate Health Care Cost Trend Rate
DefinedBenefitPlanUltimateHealthCareCostTrendRate
0.05 pure
CY2015 us-gaap Defined Benefit Plan Effect Of One Percentage Point Increase On Service And Interest Cost Components
DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents
3700000 USD
CY2015 us-gaap Defined Benefit Plan Effect Of One Percentage Point Increase On Accumulated Postretirement Benefit Obligation
DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation
77100000 USD
CY2015 us-gaap Defined Benefit Plan Effect Of One Percentage Point Decrease On Service And Interest Cost Components1
DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1
3200000 USD
CY2015 us-gaap Defined Benefit Plan Effect Of One Percentage Point Decrease On Accumulated Postretirement Benefit Obligation1
DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1
68900000 USD
CY2014Q2 us-gaap Defined Benefit Plan Accumulated Benefit Obligation
DefinedBenefitPlanAccumulatedBenefitObligation
5093100000 USD
CY2015Q2 us-gaap Defined Benefit Plan Accumulated Benefit Obligation
DefinedBenefitPlanAccumulatedBenefitObligation
5750400000 USD
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
1749000000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
1495700000 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-8700000 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
21300000 USD
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
19200000 USD
CY2015Q2 us-gaap Prescription Drug Subsidy Receipts Next Twelve Months
PrescriptionDrugSubsidyReceiptsNextTwelveMonths
4800000 USD
CY2015Q2 us-gaap Prescription Drug Subsidy Receipts Year Two1
PrescriptionDrugSubsidyReceiptsYearTwo1
5200000 USD
CY2015Q2 us-gaap Prescription Drug Subsidy Receipts Year Three1
PrescriptionDrugSubsidyReceiptsYearThree1
5600000 USD
CY2015Q2 us-gaap Prescription Drug Subsidy Receipts Year Four1
PrescriptionDrugSubsidyReceiptsYearFour1
6000000 USD
CY2015Q2 us-gaap Prescription Drug Subsidy Receipts Year Five1
PrescriptionDrugSubsidyReceiptsYearFive1
5500000 USD
CY2015Q2 us-gaap Prescription Drug Subsidy Receipts After Year Five
PrescriptionDrugSubsidyReceiptsAfterYearFive
23600000 USD
CY2015Q2 gis Net Assets Money Purchase Plan
NetAssetsMoneyPurchasePlan
21900000 USD
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
44000000 USD
CY2015Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
7500000 shares
CY2014Q2 gis Net Assets Money Purchase Plan
NetAssetsMoneyPurchasePlan
20600000 USD
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
44800000 USD
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
46000000 USD
CY2014Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
8400000 shares
CY2015Q2 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
655600000 USD
CY2014Q2 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
708200000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1338600000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2181400000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2051200000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
423300000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
473600000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
483700000 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
392700000 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
526700000 USD
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
493400000 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
29300000 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
37800000 USD
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
39500000 USD
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
139500000 USD
CY2014 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
146300000 USD
CY2013 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
126500000 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
561500000 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
710800000 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
659400000 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
70300000 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
159100000 USD
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
68800000 USD
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-36300000 USD
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-7900000 USD
CY2013 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-6200000 USD
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.007 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.014 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.013 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.031 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.001 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.006 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
-0.029 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
-0.021 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
-0.023 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.009 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.006 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.007 pure
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.333 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.333 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.292 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Deductions Medicare Prescription Drug Benefit
EffectiveIncomeTaxRateReconciliationDeductionsMedicarePrescriptionDrugBenefit
0 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Deductions Medicare Prescription Drug Benefit
EffectiveIncomeTaxRateReconciliationDeductionsMedicarePrescriptionDrugBenefit
0 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Deductions Medicare Prescription Drug Benefit
EffectiveIncomeTaxRateReconciliationDeductionsMedicarePrescriptionDrugBenefit
-0.013 pure
CY2015 gis Effective Income Tax Rate Deferred Tax Adjustment For Subsidiary Restructuring
EffectiveIncomeTaxRateDeferredTaxAdjustmentForSubsidiaryRestructuring
0 pure
CY2014 gis Effective Income Tax Rate Deferred Tax Adjustment For Subsidiary Restructuring
EffectiveIncomeTaxRateDeferredTaxAdjustmentForSubsidiaryRestructuring
0 pure
CY2013 gis Effective Income Tax Rate Deferred Tax Adjustment For Subsidiary Restructuring
EffectiveIncomeTaxRateDeferredTaxAdjustmentForSubsidiaryRestructuring
-0.025 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0.045 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0 pure
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
98000000 USD
CY2015Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
5600000 USD
CY2015Q2 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
6100000 USD
CY2015Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
89300000 USD
CY2015Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
74500000 USD
CY2015Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1363600000 USD
CY2015Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
215400000 USD
CY2015Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1148200000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1346300000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
446500000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
50800000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
14200000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2598400000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2731200000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
45000000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
53100000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
499400000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1373400000 USD
CY2014Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1139300000 USD
CY2014Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
221600000 USD
CY2014Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1360900000 USD
CY2014Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
117700000 USD
CY2014Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
71400000 USD
CY2014Q2 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
13000000 USD
CY2014Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
78900000 USD
CY2014Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
106000000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
59700000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
60600000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
0 USD
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
536200000 USD
CY2014Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
546000000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
22800000 USD
CY2015Q2 us-gaap Deferred Tax Assets Hedging Transactions
DeferredTaxAssetsHedgingTransactions
800000 USD
CY2014Q2 us-gaap Deferred Tax Assets Hedging Transactions
DeferredTaxAssetsHedgingTransactions
0 USD
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
169000000 USD
CY2014Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
-2000000 USD
CY2015Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-1450200000 USD
CY2014Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-1591900000 USD
CY2015Q2 us-gaap Deferred Tax Liabilities Other Finite Lived Assets
DeferredTaxLiabilitiesOtherFiniteLivedAssets
208400000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Other Finite Lived Assets
DeferredTaxLiabilitiesOtherFiniteLivedAssets
204200000 USD
CY2015Q2 gis Deferred Tax Assets Unrealized Losses On Investments
DeferredTaxAssetsUnrealizedLossesOnInvestments
384100000 USD
CY2014Q2 gis Deferred Tax Assets Unrealized Losses On Investments
DeferredTaxAssetsUnrealizedLossesOnInvestments
427900000 USD
CY2014Q2 gis Deferred Tax Liabilities Unrealized Gains On Investments
DeferredTaxLiabilitiesUnrealizedGainsOnInvestments
470700000 USD
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
108400000 USD
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
76200000 USD
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
56900000 USD
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
45000000 USD
CY2015Q2 gis Deferred Tax Liabilities Unrealized Gains On Investments
DeferredTaxLiabilitiesUnrealizedGainsOnInvestments
472500000 USD
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
34800000 USD
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
26500000 USD
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
17400000 USD
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
15100000 USD
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
-21800000 USD
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
-94500000 USD
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
-12000000 USD
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
-5400000 USD
CY2015 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
-8200000 USD
CY2014 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
-7000000 USD
CY2015Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
161100000 USD
CY2014Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
150900000 USD
CY2013Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
216200000 USD
CY2015Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
84000000 USD
CY2015 us-gaap Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense
DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense
160900000 USD
CY2015 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
200000 USD
CY2015Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
35200000 USD
CY2014 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
4600000 USD
CY2014Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
42000000 USD
CY2010 gis Deferred Tax Expense Benefit Related To Medicare Prescription Drug Benefit
DeferredTaxExpenseBenefitRelatedToMedicarePrescriptionDrugBenefit
35000000 USD
CY2013 gis Deferred Tax Expense Benefit Related To Medicare Prescription Drug Benefit
DeferredTaxExpenseBenefitRelatedToMedicarePrescriptionDrugBenefit
-33700000 USD
CY2012Q3 gis Deferred Tax Expense Benefit Related To Subsidiary Restructuring
DeferredTaxExpenseBenefitRelatedToSubsidiaryRestructuring
-63300000 USD
CY2015Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
1400000 USD
CY2015Q2 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
1900000000 USD
CY2015 us-gaap Foreign Earnings Repatriated
ForeignEarningsRepatriated
606100000 USD
CY2015 gis Discrete Tax Charge Related To Foreign Earnings Repatriated
DiscreteTaxChargeRelatedToForeignEarningsRepatriated
78600000 USD
CY2015Q2 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
47800000 USD
CY2015Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
89900000 USD
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
193500000 USD
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
189000000 USD
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
187900000 USD
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
400500000 USD
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
1500000 USD
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
100000 USD
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
1400000 USD
CY2015Q2 gis Guarantee Obligations Maximum Exposure Consolidated Subsidiaries
GuaranteeObligationsMaximumExposureConsolidatedSubsidiaries
434400000 USD
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
32400000 USD
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
81600000 USD
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
600000 USD
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
400000 USD
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
200000 USD
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
200000 USD
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
100000 USD
CY2015Q2 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2015Q2 us-gaap Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
4100000 USD
CY2015Q2 gis Guarantee Obligations Maximum Exposure Non Consolidated Affiliates
GuaranteeObligationsMaximumExposureNonConsolidatedAffiliates
258500000 USD
CY2015 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
334200000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
867300000 USD
CY2015Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1412000000 USD
CY2014Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1504600000 USD
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25300000 USD
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
21000000 USD
CY2015Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
390800000 USD
CY2015Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1268600000 USD
CY2015Q2 us-gaap Other Inventory Purchased Goods
OtherInventoryPurchasedGoods
95700000 USD
CY2015Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
214200000 USD
CY2014Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1260200000 USD
CY2014Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
419000000 USD
CY2014Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
216900000 USD
CY2014Q2 us-gaap Other Inventory Purchased Goods
OtherInventoryPurchasedGoods
97100000 USD
CY2015Q2 us-gaap Lifo Inventory Amount
LIFOInventoryAmount
867500000 USD
CY2014Q2 us-gaap Lifo Inventory Amount
LIFOInventoryAmount
904200000 USD
CY2015Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
169300000 USD
CY2015Q2 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
80900000 USD
CY2015Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
148800000 USD
CY2015Q2 gis Grain Derivative Asset Not Designated As Hedging Instrument Fair Value Current
GrainDerivativeAssetNotDesignatedAsHedgingInstrumentFairValueCurrent
3300000 USD
CY2015Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
21500000 USD
CY2015Q2 us-gaap Other Assets Current
OtherAssetsCurrent
423800000 USD
CY2014Q2 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
33300000 USD
CY2014Q2 us-gaap Other Assets Current
OtherAssetsCurrent
409100000 USD
CY2014Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
27200000 USD
CY2014Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
153900000 USD
CY2014Q2 gis Grain Derivative Asset Not Designated As Hedging Instrument Fair Value Current
GrainDerivativeAssetNotDesignatedAsHedgingInstrumentFairValueCurrent
7500000 USD
CY2014Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
187200000 USD
CY2015Q2 us-gaap Land
Land
96000000 USD
CY2015Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2298700000 USD
CY2015Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
6018100000 USD
CY2015Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
499000000 USD
CY2015Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
622200000 USD
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9544100000 USD
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5760800000 USD
CY2014Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
600800000 USD
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9393100000 USD
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5451200000 USD
CY2014Q2 us-gaap Land
Land
106900000 USD
CY2014Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2228400000 USD
CY2014Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5979700000 USD
CY2014Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
468000000 USD
CY2015Q2 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
138200000 USD
CY2015Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
530600000 USD
CY2015Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
117500000 USD
CY2014Q2 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
432200000 USD
CY2014Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
507500000 USD
CY2014Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
111800000 USD
CY2015Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
26600000 USD
CY2014Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
25800000 USD
CY2015Q2 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
30700000 USD
CY2014Q2 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
68200000 USD
CY2015Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
564700000 USD
CY2014Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
578200000 USD
CY2015Q2 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
122900000 USD
CY2014Q2 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
23100000 USD
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
390100000 USD
CY2014 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
323400000 USD
CY2014 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
-4900000 USD
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
361800000 USD
CY2015Q2 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
91800000 USD
CY2014Q2 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
92500000 USD
CY2014Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
63100000 USD
CY2014Q2 gis Grain Derivative Liability Not Designated As Hedging Instrument Fair Value Current
GrainDerivativeLiabilityNotDesignatedAsHedgingInstrumentFairValueCurrent
4800000 USD
CY2015Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
27900000 USD
CY2014Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
33500000 USD
CY2015Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
271500000 USD
CY2014Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
261100000 USD
CY2015Q2 gis Deferred Compensation And Pension Postemployment And Other Postretirement Defined Benefit Plans Liability Classified Noncurrent
DeferredCompensationAndPensionPostemploymentAndOtherPostretirementDefinedBenefitPlansLiabilityClassifiedNoncurrent
1451400000 USD
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
16100000 USD
CY2013 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
333800000 USD
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
12600000 USD
CY2013 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
-4300000 USD
CY2015Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
20700000 USD
CY2015Q2 gis Grain Derivative Liability Not Designated As Hedging Instrument Fair Value Current
GrainDerivativeLiabilityNotDesignatedAsHedgingInstrumentFairValueCurrent
7800000 USD
CY2015Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
202500000 USD
CY2015 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
335500000 USD
CY2015 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
-6900000 USD
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
13200000 USD
CY2014Q2 gis Deferred Compensation And Pension Postemployment And Other Postretirement Defined Benefit Plans Liability Classified Noncurrent
DeferredCompensationAndPensionPostemploymentAndOtherPostretirementDefinedBenefitPlansLiabilityClassifiedNoncurrent
1341900000 USD
CY2014Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
195600000 USD
CY2015Q2 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
90900000 USD
CY2014Q2 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
105700000 USD
CY2015 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
588300000 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
229400000 USD
CY2015 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
823100000 USD
CY2014 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
869500000 USD
CY2014 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
585400000 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
243600000 USD
CY2013 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
895000000 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
237900000 USD
CY2013 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
588000000 USD
CY2015 us-gaap Interest Paid Net
InterestPaidNet
305300000 USD
CY2015 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
562600000 USD
CY2014 us-gaap Interest Paid Net
InterestPaidNet
288300000 USD
CY2014 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
757200000 USD
CY2013 us-gaap Interest Paid Net
InterestPaidNet
293000000 USD
CY2013 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
569400000 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
1375900000 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
1512700000 USD
us-gaap Gross Profit
GrossProfit
1515500000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
1482400000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
345200000 USD
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4268400000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4372700000 USD
CY2014Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4712200000 USD
CY2013Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4875700000 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4350900000 USD
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4377400000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4298800000 USD
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4283800000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
1438700000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
1613000000 USD
CY2014Q4 us-gaap Gross Profit
GrossProfit
1619100000 USD
CY2013Q4 us-gaap Gross Profit
GrossProfit
1761700000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
459300000 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
346100000 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
549900000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
343200000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
410600000 USD
us-gaap Net Income Loss
NetIncomeLoss
186800000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
404600000 USD
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2014Q3 gis Market Price Of Common Stock High
MarketPriceOfCommonStockHigh
55.56
CY2014Q3 gis Market Price Of Common Stock Low
MarketPriceOfCommonStockLow
50.15
CY2014Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.41
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2014Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.41
CY2014Q4 gis Market Price Of Common Stock Low
MarketPriceOfCommonStockLow
48.86
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2014Q4 gis Market Price Of Common Stock High
MarketPriceOfCommonStockHigh
53.82
CY2015Q1 gis Market Price Of Common Stock Low
MarketPriceOfCommonStockLow
51.13
CY2015Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.41
CY2015Q1 gis Market Price Of Common Stock High
MarketPriceOfCommonStockHigh
55.11
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2013Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.38
CY2013Q4 gis Market Price Of Common Stock Low
MarketPriceOfCommonStockLow
47.41
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.84
CY2013Q4 gis Market Price Of Common Stock High
MarketPriceOfCommonStockHigh
51.53
CY2013Q3 gis Market Price Of Common Stock High
MarketPriceOfCommonStockHigh
52.73
CY2013Q3 gis Market Price Of Common Stock Low
MarketPriceOfCommonStockLow
47.08
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2013Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.38
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2014Q2 gis Market Price Of Common Stock High
MarketPriceOfCommonStockHigh
54.40
CY2014Q2 gis Market Price Of Common Stock Low
MarketPriceOfCommonStockLow
49.66
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2014Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.41
CY2015Q2 gis Market Price Of Common Stock High
MarketPriceOfCommonStockHigh
57.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2015Q2 gis Market Price Of Common Stock Low
MarketPriceOfCommonStockLow
51.70
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.44
CY2014Q1 gis Market Price Of Common Stock High
MarketPriceOfCommonStockHigh
51.50
CY2014Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.38
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2014Q1 gis Market Price Of Common Stock Low
MarketPriceOfCommonStockLow
46.86
us-gaap Foreign Earnings Repatriated
ForeignEarningsRepatriated
606100000 USD
gis Discrete Tax Charge Related To Foreign Earnings Repatriated
DiscreteTaxChargeRelatedToForeignEarningsRepatriated
78600000 USD

Files In Submission

Name View Source Status
0001193125-15-245476-index-headers.html Edgar Link pending
0001193125-15-245476-index.html Edgar Link pending
0001193125-15-245476.txt Edgar Link pending
0001193125-15-245476-xbrl.zip Edgar Link pending
d947722d10k.htm Edgar Link pending
d947722dex106.htm Edgar Link pending
d947722dex121.htm Edgar Link pending
d947722dex211.htm Edgar Link pending
d947722dex231.htm Edgar Link pending
d947722dex311.htm Edgar Link pending
d947722dex312.htm Edgar Link pending
d947722dex321.htm Edgar Link pending
d947722dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gis-20150531.xml Edgar Link completed
gis-20150531.xsd Edgar Link pending
gis-20150531_cal.xml Edgar Link unprocessable
gis-20150531_def.xml Edgar Link unprocessable
gis-20150531_lab.xml Edgar Link unprocessable
gis-20150531_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending